APA (7th ed.) Citation

Saiz-Rodríguez, M., Ochoa, D., Belmonte, C., Román, M., Vieira de Lara, D., Zubiaur, P., . . . Abad-Santos, F. (2019). Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics. Journal of psychopharmacology (Oxford), 33(4), 522. https://doi.org/10.1177/0269881119827959

Chicago Style (17th ed.) Citation

Saiz-Rodríguez, Miriam, Dolores Ochoa, Carmen Belmonte, Manuel Román, Danilo Vieira de Lara, Pablo Zubiaur, Dora Koller, Gina Mejía, and Francisco Abad-Santos. "Polymorphisms in CYP1A2, CYP2C9 and ABCB1 Affect Agomelatine Pharmacokinetics." Journal of Psychopharmacology (Oxford) 33, no. 4 (2019): 522. https://doi.org/10.1177/0269881119827959.

MLA (9th ed.) Citation

Saiz-Rodríguez, Miriam, et al. "Polymorphisms in CYP1A2, CYP2C9 and ABCB1 Affect Agomelatine Pharmacokinetics." Journal of Psychopharmacology (Oxford), vol. 33, no. 4, 2019, p. 522, https://doi.org/10.1177/0269881119827959.